A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

Using FoundationOne Liquid, a novel liquid biopsy test providing targeted gene and microsatellite instability-high results, researchers sought to examine whether specific biomarkers contribute to TNBC ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...

Biopsies are a necessary burden for people with cancer. Taking a small sample of tissue and sending it through genetic and molecular analysis can help doctors not just diagnose cancer, but also learn ...

IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the American Society of Clinical Oncology (ASCO) 2022 annual meeting data showcasing its ...

A new liquid biopsy test could detect microsatellite instability and tumor mutational burden, which can distinguish which patients are likely to respond to immune checkpoint inhibitors. A liquid ...

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before ...

New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.

A company developing liquid biopsy technology for the early detection of cancers has new data that it is presenting Saturday at a major cancer conference. Menlo Park, California-based Grail said it ...

PALO ALTO, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s ...